Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of the American Society of Nephrology

• Publication date

  1998-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9773787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus.

  1997cited by this paper
• Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptors.

  1997cited by this paper
• Molecular analysis of X-linked nephrogenic diabetes insipidus.

  1996cited by this paper
• A fully active nonglycosylated V2 vasopressin receptor.

  1996cited by this paper
• Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co‐expressed receptor polypeptide.

  1996cited by this paper
• Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.

  1996cited by this paper
• Three Novel AVPR2 Mutations in Three Japanese Families with X-Linked Nephrogenic Diabetes Insipidus

  1996cited by this paper
• Functional characterization of five V2 vasopressin receptor gene mutations.

  1996cited by this paper
• A low-affinity vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus.

  1996cited by this paper
• Diabetes insipidus.

  1995cited by this paper
• The Binding Site of Neuropeptide Vasopressin V1a Receptor

  1995cited by this paper
• Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.

  1995cited by this paper
• Expression studies of two vasopressin V2 receptor gene mutations, R202C and 804insG, in nephrogenic diabetes insipidus.

  1995cited by this paper
• A Conserved NPLFY Sequence Contributes to Agonist Binding and Signal Transduction but Is Not an Internalization Signal for the Type 1 Angiotensin II Receptor (*)

  1995cited by this paper
• Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.

  1995cited by this paper
• The effect of eight V2 vasopressin receptor mutations on stimulation of adenylyl cyclase and binding to vasopressin.

  1994cited by this paper
• An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.

  1994cited by this paper
• Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus.

  1994cited by this paper
• Functional role of proline and tryptophan residues highly conserved among G protein‐coupled receptors studied by mutational analysis of the m3 muscarinic receptor.

  1993cited by this paper
• Projection structure of rhodopsin

  1993cited by this paper
• Molecular cloning and expression of a rat Via arginine vasopressin receptor

  1992cited by this paper
• Structure and expression of a human oxytocin receptor

  1992cited by this paper
• Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus

  1992cited by this paper
• Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa.

  1991cited by this paper
• The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein.

  1990cited by this paper
• Molecular cloning and expression of a receptor for human tumor necrosis factor.

  1990cited by this paper
• Three-dimensional modelling of G protein-linked receptors.

  1990cited by this paper
• Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function.

  1989cited by this paper
• Calculating receptor number from binding experiments using same compound as radioligand and competitor.

  1989cited by this paper
• Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin.

  1988cited by this paper
• The MIDAS display system

  1988cited by this paper
• Immunocytochemical localization of mutant low density lipoprotein receptors that fail to reach the Golgi complex

  1988cited by this paper
• Identification of residues required for ligand binding to the beta-adrenergic receptor.

  1987cited by this paper
• Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product

  1985cited by this paper
• [3H]Vasopressin binding to rat hippocampal synaptic plasma membrane

  1983cited by this paper
• A highly sensitive adenylate cyclase assay.

  1974cited by this paper
• Nephrogenic Diabetes Insipidus

  1963cited by this paper

• Phenotype and renal outcomes of patients with congenital arginine vasopressin-resistance.

  2025cites this paper
• Vasopressin and oxytocin receptors in GtoPdb v.2025.3

  2025cites this paper
• Nephrogenic diabetes insipidus results from a novel in-frame deletion of AVPR2 gene in monozygotic-twin boys and their mother and grandmother

  2024cites this paper
• Aquaporins in Diabetes Insipidus.

  2023cites this paper
• V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology

  2023influential citation
• Vasopressin and oxytocin receptors in GtoPdb v.2023.1

  2023cites this paper
• Structure of the vasopressin hormone–V2 receptor–β-arrestin1 ternary complex

  2022influential citation
• Genetic basis of nephrogenic diabetes insipidus.

  2022cites this paper
• Class A and C GPCR Dimers in Neurodegenerative Diseases

  2022cites this paper
• Pregnancy-associated diabetes insipidus in Japan-a review based on quoting from the literatures reported during the period from 1982 to 2019.

  2021cites this paper
• Cryo–electron microscopy structure of the antidiuretic hormone arginine-vasopressin V2 receptor signaling complex

  2021cites this paper
• Receptor Transduction Pathways Mediating Hormone Action

  2021cites this paper
• Novel AVPR2 mutations and clinical characteristics in 28 Chinese families with congenital nephrogenic diabetes insipidus

  2021cites this paper
• Biased signaling in naturally occurring mutations of G protein-coupled receptors associated with diverse human diseases.

  2020cites this paper
• A female with X‐linked Nephrogenic diabetes insipidus in a family with inherited central diabetes Insipidus: Case report and review of the literature

  2020cites this paper
• V2 vasopressin receptor mutations.

  2020cites this paper
• Vasopressin and oxytocin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Protein misfolding in endoplasmic reticulum stress with applications to renal diseases.

  2019cites this paper
• Misfolding of vasopressin receptors: biased agonist pharmacochaperones as potential therapeutics.

  2019cites this paper
• Chemical validation and optimization of pharmacoperones targeting vasopressin type 2 receptor mutant.

  2018cites this paper
• Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors.

  2018cites this paper
• Biased Agonist Pharmacochaperones: Small Molecules in the Toolbox for Selectively Modulating GPCR Activity

  2017cites this paper
• Genetics of Diabetes Insipidus.

  2017cites this paper
• Diabetes Insipidus.

  2017cites this paper
• Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias

  2017cites this paper
• Characterization of vasopressin V 2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model

  2017cites this paper
• Novel AVPR2 mutation causing partial nephrogenic diabetes insipidus in a Japanese family

  2016cites this paper
• Patologías del receptor V2 de la vasopresina: diabetes insípida nefrógena congénita y síndrome nefrógeno de antidiuresis inapropiada

  2016cites this paper
• Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist*

  2016cites this paper
• Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study

  2015influential citation
• Effect of mutations in putative hormone binding sites on V2 vasopressin receptor function

  2015cites this paper
• How genetic errors in GPCRs affect their function: Possible therapeutic strategies

  2015cites this paper
• Study of V2 vasopressin receptor hormone binding site using in silico methods

  2015cites this paper
• Nephrogenic diabetes insipidus in children

  2015cites this paper
• Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus

  2015cites this paper
• Vasopressin receptors and pharmacological chaperones: from functional rescue to promising therapeutic strategies.

  2014cites this paper
• [Vasopressin V2 receptor-related pathologies: congenital nephrogenic diabetes insipidus and nephrogenic syndrome of inappropiate antidiuresis].

  2014cites this paper
• Altered agonist sensitivity of a mutant v2 receptor suggests a novel therapeutic strategy for nephrogenic diabetes insipidus.

  2014cites this paper
• Urinary concentration: different ways to open and close the tap

  2014cites this paper
• Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.

  2013cites this paper
• Physiologie et physiopathologie de la soif

  2013cites this paper
• Interactions of vasopressin and oxytocin receptors with vasopressin analogues substituted in position 2 with 3,3′‐diphenylalanine – a molecular docking study

  2013cites this paper
• Culturing primary rat inner medullary collecting duct cells.

  2013cites this paper
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cites this paper
• Congenital nephrogenic diabetes insipidus: the current state of affairs

  2012cites this paper
• Conséquences fonctionnelles de mutations affectant le récepteur de la vasopressine de type 2 et implications thérapeutiques

  2012cites this paper
• Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.

  2012influential citation
• Inherited Disorders of the Renal Tubule

  2012cites this paper
• Nephrogenic diabetes insipidus.

  2012cites this paper
• A patient with polyuria and hydronephrosis: answer

  2011cites this paper
• The kidney speaks: interpreting urinary sodium and osmolality

  2011cites this paper
• A patient with polyuria and hydronephrosis: question

  2011cites this paper
• V2 Vasopressin Receptor (V2R) Mutations in Partial Nephrogenic Diabetes Insipidus Highlight Protean Agonism of V2R Antagonists*

  2011cites this paper
• Familial forms of diabetes insipidus: clinical and molecular characteristics

  2011cites this paper
• Functional Characterization of Vasopressin Receptor 2 Mutations Causing Partial and Complete Congenital Nephrogenic Diabetes Insipidus in Thai Families

  2010cites this paper
• Chapter 15. Disorders of Water Balance

  2010cites this paper
• Pharmacological Chaperones: Potential for the Treatment of Hereditary Diseases Caused by Mutations in G Protein‐Coupled Receptors

  2010cites this paper
• An Influence of the Aromatic Side Chains Conformations in Positions 2 and 3 of Vasopressin Analogs on Interactions with Vasopressin and Oxytocin Receptors

  2009cites this paper
• Vasopressin Type 2 Receptor V88M Mutation: Molecular Basis of Partial and Complete Nephrogenic Diabetes Insipidus

  2009cites this paper
• Caractérisation et étude d'un élément régulateur du gène codant pour le récepteur à la vasopressine de type 2

  2009cites this paper
• Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus.

  2009cites this paper
• Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus.

  2009cites this paper
• Diverse vasopressin V 2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus

  2009cites this paper
• CHAPTER 2 – Receptor Transduction of Hormone Action

  2008cites this paper
• AVPR2 variants and mutations in nephrogenic diabetes insipidus: Review and missense mutation significance

  2008cites this paper
• Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene

  2008cites this paper
• A novel disease-causing mutation in AVPR2: Q96H

  2008cites this paper
• Theoretical Study on Interactions of Bicyclic Vasopressin Analogues with Human Neurohypophyseal Hormone Receptors

  2008cites this paper
• Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.

  2007cites this paper
• Water in health and disease: new aspects of disturbances in water metabolism.

  2007cites this paper
• Correlation Between AVPR2 Mutations and Urinary AQP2 Excretion in Patients with Nephrogenic Diabetes Insipidus

  2007cites this paper
• Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.

  2006influential citation
• Mechanisms of Disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases

  2006cites this paper
• Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: Molecular dynamics simulation of the agonist‐bound state in the membrane–aqueous system

  2006cites this paper
• Nephrogenic diabetes insipidus.

  2006cites this paper
• Molecular basis and clinical features of nephrogenic diabetes insipidus

  2006cites this paper
• nephrogenic diabetes insipidus receptor and aquaporin 2 water channel in Cell biological aspects of the vasopressin type-2

  2006cites this paper
• Oligomérisation des récepteurs couplés aux protéines G : deux ou plus ? Application des technologies de FRET en temps résolu au cas du récepteur GABAB

  2006cites this paper
• Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications.

  2006cites this paper
• Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.

  2005cites this paper
• [Congenital nephrogenic diabetes insipidus].

  2005cites this paper
• Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.

  2005cites this paper
• Les récepteurs de la vasopressine : structure fonctionnelle et transduction signalétique dans les cellules cibles

  2005cites this paper
• Pharmacological chaperone action on G-protein-coupled receptors.

  2004cites this paper
• Cell surface detection of membrane protein interaction with HTRF® technology

  2004cites this paper
• Neuroendocrine control of body fluid metabolism.

  2004cites this paper
• Cell surface detection of membrane protein interaction with homogeneous time-resolved fluorescence resonance energy transfer technology.

  2004cites this paper
• Pharmacochaperones Post-translationally Enhance Cell Surface Expression by Increasing Conformational Stability of Wild-type and Mutant Vasopressin V2 Receptors*

  2004cites this paper
• The early stages of the intracellular transport of membrane proteins: clinical and pharmacological implications.

  2004cites this paper
• Intrafamilial phenotype variability in nephrogenic diabetes insipidus.

  2002cites this paper
• Diabète insipide néphrogénique congénital

  2002cites this paper
• [Congenital nephrogenic diabetes insipidus].

  2002cites this paper
• Molecular and cellular defects in nephrogenic diabetes insipidus

  2001cites this paper
• Nephrogenic diabetes insipidus.

  2001cites this paper
• Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus.

  2001cites this paper
• Molekulare Grundlagen des Diabetes insipidus centralis und renalis

  2001influential citation
• The V2 vasopressin receptor mutations and fluid homeostasis.

  2001cites this paper
• Functional Rescue of the Nephrogenic Diabetes Insipidus-causing Vasopressin V2 Receptor Mutants G185C and R202C by a Second Site Suppressor Mutation*

  2001cites this paper
• Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.

  2000cites this paper
• Nephrogenic diabetes insipidus: functional analysis of new AVPR2 mutations identified in Italian families.

  2000cites this paper